Dec 6, 2025
How to Recognize Labeling Errors and Ask for Corrections in Machine Learning Datasets
The FDA doesn't rate biosimilars like generics-it evaluates them through a rigorous scientific process to prove they're highly similar and safe. Learn how biosimilars are approved, why they're different from generics, and what the Purple Book means for patients.